View Article

Abstract

This review explores the formulation of a functional beverage aimed at supporting the health of pre-diabetic individuals using indigenous antidiabetic plant-based ingredients. The primary active pharmaceutical ingredient (API) in the formulation is Fenugreek (Trigonella foenum-graecum),widely known for its ability to regulate blood glucose levels through mechanisms such as delayed gastric emptying and improved insulin sensitivity. Complementary excipients used in the beverage include stevia, a natural, non-caloric sweetener; citric acid for flavor enhancement and pH regulation; guar gum as a thickening agent and fiber source; natural lemon flavor for taste masking and consumer acceptability; ascorbic acid (vitamin C) for its antioxidant stability; and purified water as the solvent base. The methodology involves optimizing ingredient ratios to maintain palatability, stability, and therapeutic efficacy. Preliminary results from various studies indicate that such formulations can improve glycemic control, provide antioxidant benefits, and offer are freshing, low-calorie alternative to sugary drinks. This review concludes that fenugreek-based functional beverages, when properly formulated with suitable excipients, hold potential as safe and effective dietary interventions for pre-diabetic individuals.

Keywords

Functional beverage, Fenugreek, Pre-diabetes, Blood glucose control, Indigenous plant therapy

Introduction

Diabetes mellitus is characterized by high blood glucose and changed fat metabolism brought on by inadequate insulin secretion and function. [1] The Egyptians were the first to record diabetes, which is distinguished by polyuria and weight reduction. The term diabetes mellitus (DM), however, was invented by the Greek doctor Aertaeus. Diabetes is the Greek word for "to pass through," and mellitus is the The term for honey in Latin, which alludes to its sweetness. With about one death every 10 seconds, diabetes causes more fatalities each year than HIV/AIDS and is a major contributor to chronic illness and premature death. Diabetes has emerged as a global epidemic as a result of the advent of industrialization and the dramatic increase in obesity. The standard and methods of data collecting differ greatly, making it hard to determine the prevalence of two major causes. In different regions of the globe, recent surveys anticipate that the percentage of adults with diabetes will rise from 4% in 1995 to 6.4% by 2025.

1. It is also predicted that it will evolve quickly, with a 170% growth in developing nations and a 42% rise from 51 to 72 million in industrialized nations. in the developing world, from 84 to 228 million. The number of adults with diabetes worldwide will increase from 194 million in 2003 to about 380 million in 2025. India, China, and the United States will be the nations most impacted by this epidemic in 2025.

2. Another cause for concern is that a sizable percentage of patients—close to 50%—remain undiagnosed even now. The shift in lifestyle The amazing increase in the prevalence of diabetes mellitus is partially attributable to expectancy and the failure to improve healthcare. Consequently, there is a rising rate of diabetes incidence, particularly in cities. As a result, the strain will increase significantly in nations all over the world. for health care, since people with diabetes are more susceptible to early mortality as well as short- and long-term consequences. [2] Diabetes Mellitus is more likely to occur in those who are older, physically inactive, obese, hypertensive, dyslipidemic, or have had gestational Diabetes Mellitus in the past. Furthermore, certain racial and ethnic groups have a significant genetic predisposition. The pathogenic process that results in Diabetes Mellitus is used as the basis for its classification. to hyperglycemia. There are two main forms of DM: Type 1 and Type 2. Both of these forms of diabetes are preceded by a period. The pathogenic mechanism is described by the category of aberrant glucose homeostasis. The remaining categories are based on etiology, such as gestational diabetes. Hyperglycemia and diabetes caused by drugs, which are linked to a wide range of causes. [3]

Types of Diabetes:

Table 1: Types of diabetes

Type of Diabetes

Description

Causes

Type 1 Diabetes

The body makes little or no insulin because the immune system destroys the cells that produce it

Body’s defence system attacks insulin-making cells

Type 2 Diabetes

The body cannot   use insulin properly or does not make enough of it

Unhealthy habits, family history, overweight

Gestational Diabetes

Diabetes that’s starts during pregnancy

Pregnancy hormones reduce insulin activity

Pre-diabetic

Sugar level is higher than the normal but not yet diabetes

Insulin not working well and poor lifestyle

Prediabetes:

If your blood sugar level is higher than usual but not high enough to be considered diabetes, you have prediabetes. Consider it a warning sign that your body is beginning to struggle with sugar, but that you are not quite diabetic.Despite the fact that prediabetes is frequently asymptomatic, it is not benign. Individuals with prediabetes have an increased chance of developing type 2 diabetes, as well as other health issues such heart disease, nerve damage, kidney problems, and eye problems.Although various health groups, such as the WHO and the ADA, have somewhat different blood sugar ranges for determining prediabetes, the fundamental concept is the same: your between diabetic and healthy sugar levels.The good news is that many individuals can postpone or even avoid type 2 diabetes by making lifestyle adjustments such as improving their diet, increasing their physical activity, and shedding a few pounds. diabetes. Lifestyle is the first and most important action, although some medications, such metformin, are also utilized in individuals at high risk. [5]

Pathophysiology:

Lifestyle Factors

(Unhealthy diet, inactivity, weight gain, etc.)

↑ Insulin Resistance

(Cells stop responding well to insulin)

↓ Pancreas Overworks to Make More Insulin

↓ β-Cell Dysfunction Begins (Less insulin production)

↓ Blood Sugar Rises Slowly (Fasting or after meals)

↓ Other Problems: -

More fat breakdown (↑ lipolysis)

- Gut hormone problems (↓ GLP-1)

- Too much glucagon (↑ liver glucose)

- Inflammation (↑ cytokines like TNF-α)

↓ PREDIABETES STAGE (Body can't fully control blood sugar anymore) [6,7,8]

Prediabetes Risk Factors:

People are more prone to getting prediabetes if they have:

I. Weight that is unhealthy, particularly fat around the abdomen                                                                       

II. Elevated blood pressure                                           

III. Unbalanced cholesterol or triglyceride levels

IV. A sedentary way of life                                         

V. Old age                                                                          

VI. Employment in the informal sector, which may be related to stress, erratic schedules, or inadequate healthcare access. 

VII. Somewhat elevated diastolic blood pressure (80–99 mmHg)

VIII. Elevated triglyceride-glucose (TyG) index, a reliable indicator of prediabetes

If these factors are present, even those without a family history of diabetes can get prediabetes. [9,10]

SYMPTOMS AND INDICATIONS:

There aren't usually any obvious symptoms of prediabetes, but some individuals may experience the following:

  1. Experiencing greater thirst than usual                    
  2. Frequently experiencing fatigue
  3. Frequent need to urinate                 
  4. Dim sight                                    
  5. Wounds that heal slowly              
  6. A lot of people don't know they have prediabetes until it's discovered in a blood test. [6,7]    

Prediabetes Complications Include:

Although prediabetes is not the same as full-blown diabetes, it can still harm the body over time. People with prediabetes are more likely to experience:

1. Advancing towards type 2 diabetes:

Around 5–10% of people get full diabetes annually. It may affect as many as 70% of people throughout their lives.

2. Issues with the heart and blood vessels (cardiovascular diseases):

Increased risk of high blood pressure, heart attack, stroke, and artery damage Particularly if there is also insulin resistance and high blood pressure, the risk rises.

3. Kidney Ailment:

Higher risk of developing chronic kidney disease

4. Diseases of the Brain and Nervous System:

Increased risk of dementia (including Alzheimer's and vascular dementia) Over time, it may also cause nerve injury (neuropathy).

5. Some Kinds of Cancer:

higher risk of malignancies in the liver, pancreas, breast, and colon.

Prohibiting Prediabetes:

Strategies to stop the development of prediabetes have been investigated, such as:

1. Changes in Lifestyle (Diet and Exercise) Overview: Motivating patients to eat healthily, reduce weight, and engage in more physical activity.

Drawbacks:

  1. It calls for sustained discipline and drive.
  2. Maintaining it consistently is challenging for the elderly and those who are employed.

iii. People with a strong genetic predisposition may not be able to overcome it just via lifestyle modifications.

2. Therapeutic Interventions (e.g., Metformin) Overview: The usage of drugs such as metformin to increase insulin sensitivity and lower glucose output from the liver.

Drawbacks:

I. Possible negative consequences include lactic acidosis and gastrointestinal distress.

ii. Not advised for all patients, especially those with liver or renal dysfunction.

iii. If underlying causes are not addressed, long-term dependency may result.

 3. Surgery for Obesity Summary: Weight reduction surgery can significantly improve insulin resistance in patients with severe obesity.

Drawbacks:

  1. Costly and invasive.

ii. Involves the possibility of surgical dangers and complications.

iii. Not required or practical for the majority of people who are prediabetic.                                                                               

4. Functional Foods and Nutraceuticals

Summary: Foods or supplements with therapeutic effects, such as cinnamon, fenugreek, or bitter melon.

Disadvantages:

i. Because of inconsistent dosage or bioavailability, efficacy might sometimes vary.

ii. Some may have powerful tastes or unpleasant flavors that make it difficult for patients to follow instructions.

iii. if taken incorrectly, there is a chance of drug interactions. [9,10]

Useful Drinks:

The nutritional worth of people's diets is now better understood. Functional beverages contain bioactive ingredients derived from plants, animals, and microbes, such as phenolic compounds, minerals, vitamins, amino acids, peptides, unsaturated fatty acids, and more.

Kinds:

1. Infused Herbal Drink

2. Decoctions Made With Plants

3. drinks with extra flavor

4. Drinks Containing Probiotics or Prebiotics

5. Drinks Rich in Fiber

6. Fruit & Vegetable Juices with a Low Glycemic Index

7. Functional lemonades or coolers sweetened with stevia

8. Functional Smoothies (with anti-diabetic herbs) [11–13]

 Importance:

Importance of herbal beverages In Africa, over 90% of the people consume herbal remedies to enhance their physical health, while in India, 70% of the population does the same. health (Saad & Prochaska, 2020). For more than a century, herbal remedies in the form of tablets, capsules, or liquids have been used as primary care. especially in poor countries with large populations. As a result, herbal beverages have been promoted as one of the options for maintaining good health. herbal remedies innovation. As a result, the use of herbal beverages is widespread, with certain beverages becoming more well-known than others depending on their geographic location. Over 80% of people in Africa and Asia still rely on herbal cures as their primary form of healthcare, according to the World Health Organization. (WHO). In order to stay healthy, certain communities around the world drank herbal beverages as part of their diet. [14]

Role of Herbal Beverage In Prediabetic Management:

The Function of Herbal Drinks in the Treatment of Prediabetes In this situation, herbal drinks provide a positive and patient-friendly solution. They combine the therapeutic advantages of traditional herbs with ease of use and deliciousness. In contrast to synthetic pharmaceuticals, herbal beverages are often tolerated well, inexpensive, and culturally acceptable in many areas. The herbal beverage that this study looked at is made using [list of herbs, such as Gymnema sylvestre, cinnamon, fenugreek, etc.] that are known for their glucose-lowering properties. Effects, enhanced insulin sensitivity, and anti-inflammatory and antioxidant qualities.

Herbal Beverages' Benefits:                                                                                                                                                           

  1. simple to integrate into everyday life and non-invasive.
  2. Fewer adverse effects than pharmacological medications.  
  3. May address a variety of metabolic processes, not just blood sugar.
  4. Improved patient adherence as a result of taste and cultural acceptability.

As a result, this study examines the efficacy of a specifically created herbal drink as a natural, safe, and efficient method for controlling prediabetes, perhaps surpassing traditional methods. strategies for sustainability and patient satisfaction. [11–13]

Herbs for Diabetic Management:

Table 2: Herbs for Diabetic Management

Common Name

Biological Source

Part Used

Images

Fenugreek

Trigonella foenum-graecum

Fruit

Neem

Azardirachta indica

Leaves, bark

Turmeric

Curuma longa

Rhizome

Amla

Emblica officinalis

Fruit

Bael

Aegle marmelos

Leaves,fruit

Cinnamon

Cinnamomum zeylanicum

Bark

Garlic

Allium sativum

Bulb

Onion

Alliumcepa

Bulb

Aloe vera

Aloe barbedadensis

Leaf gel

Elected Phytoconstituents And Additives for Formulation Development:

For the creation of the formula, we chose certain phytoconstituents and additives. It has been said that around 800 plants have the potential to treat diabetes. The use of many bioactive chemicals (active principles) derived from plants in the prevention and treatment of diabetes has already been demonstrated in a variety of laboratory settings. research, however, has not shown it to be effective for therapeutic applications.

1. Trigonella foenum graecum, or fenugreek, is a therapeutic plant belonging to the Fabaceae family that is used to treat a variety of ailments, including diabetes, inflammation, cancer, neurodegenerative illnesses, reproductive problems, and hypercholesteremia. Fenugreek seeds have been used for ages as carminative, demulcent, expectorant, laxative, and stomachic remedies. It has its roots in It originated in Eastern Europe, but is now cultivated everywhere. It contains a variety of phytochemicals, including Address correspondence to this author at the India, Uttar Pradesh, Aligarh, Aligarh Muslim University, Faculty of Life Sciences, Department of Zoology, Section of Genetics, Drosophila Transgenic Laboratory, 202002; flavonoids, alkaloids, coumarins, vitamins, carbohydrates (Galactomannan) The pharmacological effects are caused by saponins, trigonelline, diosgenin, and soluble fibers. Its anti-diabetic, anti-sterility, and anti-fertility characteristics have been demonstrated by several clinical and preclinical investigations. Additionally, it governs the creation of enzymes that regulate blood sugar levels and aid in lowering cholesterol. The hypoglycemic effect of fenugreek corresponds to physiological needs and are influenced by the amount of Glucogen-like peptide-1. [15–17]

Fig 1: Trigonella foenum graecum, or fenugreek

One of the earliest herbs used for therapeutic purposes in India, fenugreek (Trigonella foenum graceum) has a history that goes back to ancient Egypt. Among the alkaloids found in fenugreek seeds are trigonelline, gentianine, and carpaine compounds. These seeds are a good source of fiber and protein, and the fiber may be broken down further. categorized as neutral detergent fiber and gum (gel fiber). The seeds also include fiber-galcatomannan, fenugreekine, a chemical that may have, and 4-hydroxyisoleucine, a unique amino acid. hypoglycemic effect.9 Although lignin, another kind of crude fiber, is of plant origin and also undigestible, it is not technically a carbohydrate. slows gastric emptying, prevents the quick absorption of glucose in the small intestine, helps diabetic individuals retain blood sugar, and may also be helpful in treating hypercholesteremia. [26]

Fig 2: Stevia rebaudiana

2. The family Asteraceae includes Stevia rebaudiana. It is indigenous to northeastern Paraguay. but is grown in other parts of the world, such as Europe, Asia, and North America. Stevia is well-known for its exceptional sweetness, which is 250 to 300 times that of sucrose. Its pleasant flavor is connected to the steviol glycosides, which are widely employed as sugar alternatives and non-caloric sweeteners. The Impact of Stevia on the Glycemic Profile: The majority of research in this area focused on the effects of stevia in diabetes (10–12), and only a small number of clinical trials looked at this topic. Animal models are used for research on the topic. [27]

Fig 3: Citric acid

3.Citric acid, Due to their pH-reducing effect, one group exhibits an antimicrobial activity primarily. This group They function either directly by reducing the pH of the by moving into the cytoplasm of the microorganism via the cell membrane in the undissociated state, or by adding stress to the food and thereby harming the microorganism. they break apart and reduce the cell's internal pH.[28]

Fig 4: Natural galactomannan

4. Natural galactomannan, which is derived from the endosperm of guar seeds, is known as guar gum. Guar belongs to a class of compounds. It is made up of indigestible carbohydrates and has been shown to be effective at lowering blood glucose levels after meals, especially when Guar granules are sprinkled on food (Jenkins et al. 1977). In addition, It has been documented that taking guar gum supplements for 48 weeks can help the lipid profile in those with type 2 diabetes mellitus (T2DM). [29]

Fig 5: Citric acid

Reference

  1. Ubaid M, Arif M, Usmani A, Anayatullah, Khan N, Dash PP, Mishra A. Advances in clinical endocrinology and metabolism: An insight to diabetes mellitus and its complications. UPCST Research Lab, Faculty of Pharmacy, Integral University, Lucknow, India; Amity Institute of Pharmacy, Lucknow, India.
  2. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus.
  3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(1):65–71.
  4. Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Centre for Endocrinology and Diabetes, Institute of Human Development, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; Weill Cornell Medical College in Qatar, Doha, Qatar.
  5. Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Centre for Endocrinology and Diabetes, Institute of Human Development, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; Weill Cornell Medical College in Qatar, Doha, Qatar.
  6. Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med. 1992; 326:22–29.
  7. Meigs JB, D’Agostino RB Sr, Nathan DM, Rifai N, Wilson PW. Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care. 2002; 25:977–983.
  8. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003; 52:102–110.
  9. Schlesinger S, Neuenschwander M, Barbaresko J, Lang A, Maalmi H, Rathmann W, et al. Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies.
  10. Lizarzaburu-Robles JC, Herman WH, Garro-Mendiola A, Galdón Sanz-Pastor A, Lorenzo O. Prediabetes and cardiometabolic risk: The need for improved diagnostic strategies and treatment to prevent diabetes and cardiovascular disease.
  11. Khan R, Chua Z, Tan J, Yang Y, Liao Z, Zhao Y. From prediabetes to diabetes: Diagnosis, treatments and translational research. Medicina. 2019;55(9):546. doi:10.3390/medicina55090546. PMID: 31470636.
  12. Tran VD, James AP, Lee AH, Jancey J, Howat PA, Thi Phuong Mai L. Effectiveness of a community-based physical activity and nutrition behavior intervention on features of the metabolic syndrome: a cluster-randomized controlled trial. Metab Syndr Relat Disord. 2017;15(2):63–71.
  13. Carvalho F, Aitfella Lahlou R, Pires P, Salgado M, Silva LR. Natural functional beverages as an approach to manage diabetes.
  14. Shaik MI, Hamdi IH, Sarbon NM. A comprehensive review on traditional herbal drinks: Physicochemical, phytochemical and pharmacological properties. Faculty of Fisheries and Food Science, Universiti Malaysia Terengganu, Kuala Nerus, Malaysia.
  15. Shabil M, Bushi G, Bodige PK, Maradi PS, Patra BP, Padhi BK, et al. Effect of fenugreek on hyperglycemia: a systematic review and meta-analysis.
  16. Kaur M, Singh N, Sharma G, Singh D. To study the efficacy and tolerability of fenugreek seed powder as add-on therapy with metformin in patients of type 2 diabetes mellitus.
  17. Visuvanathan T, Than LTL, Stanslas J, Chew SY, Vellasamy S. Revisiting Trigonella foenum-graecum L.: Pharmacology and therapeutic potentialities.
  18. Gupta S, Kataria M, Gupta PK, Murganandan S, Yashroy RC. Protective role of extracts of neem seeds in diabetes caused by streptozotocin in rats. Indian Vet Res Inst, Izatnagar, India. 2003.
  19. Maithili Karpaga Selvi N, Sridhar MG, Swaminathan RP, Sripradha R. Efficacy of turmeric as adjuvant therapy in type 2 diabetic patients.
  20. Walia K, Boolchandani R. Role of amla in type 2 diabetes mellitus: a review. Univ Rajasthan, Jaipur, India. 2015. Available from: www.isca.in
  21. Sharma K, Shukla S, Chauhan ES. Evaluation of Aegle marmelos (Bael) as hyperglycemic and hyperlipidemic diminishing agent in type II diabetes mellitus subjects.
  22. Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. College of Pharmacy, Western University of Health Sciences, Pomona, CA; Western Diabetes Institute, Pomona, CA; School of Pharmacy and School of Medicine, University of Connecticut, Storrs and Farmington, CT.
  23. Padiya R, Banerjee SK. Garlic as an anti-diabetic agent: recent progress and patent reviews. Division of Pharmacology, Indian Institute of Chemical Technology, Hyderabad, India; 2012 Oct 17; revised 2012 Dec 14; accepted 2012 Dec 14.
  24. Taj Eldin IM, Ahmed EM, Abd Elwahab HM. Preliminary study of the clinical hypoglycemic effects of Allium cepa (red onion) in type 1 and type 2 diabetic patients. Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Sudan; Department of Chemistry and Pharmacognosy, Faculty of Pharmacy, University of Gezira, Sudan; Department of Pharmacology and Toxicology, Medicinal and Aromatic Plant Research Institute, National Center for Research, Sudan.
  25. Suksomboon N, Poolsup N, Punthanitisarn S. Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis. Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok; Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.
  26. Varshney H, Siddique YH. Medicinal properties of fenugreek: a review. Department of Zoology, Drosophila Transgenic Laboratory, Section of Genetics, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
  27. Masoumi SJ, Ranjbar S, Keshavarz V. The effectiveness of Stevia in diabetes mellitus: a review. Nutrition Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  28. Meyer A, Suhr K, Nielsen P, Holm F. Natural food preservatives. Technical University of Denmark, Lyngby; FoodGroup Denmark, Aarhus.
  29. Li J, Chen R, Chen Y, Zhu D, Wu Z, Chen F, Huang X, Khan BA, Al Hennawi HE, Albazee E, Prabahar K, Hou K. The effect of guar gum consumption on the lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
  30. Taylor AJ, Linforth RST, editors. Food flavour technology. 2nd ed. Division of Food Sciences, University of Nottingham, UK; Bakker J, Law BA. Understanding natural flavours. In: Piggott JR, Paterson A, editors. London: Chapman and Hall; 1994. p. 283–295.
  31. Carvalho F, Lahlou RA, Pires P, Salgado M, Silva LR. Natural functional beverages as an approach to manage diabetes.
  32. Kumar P, Singh SK, Singh B. Standardization of methodology for the preparation of beverages and studies during preservation. Department of Agricultural Engineering and Food Technology, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, Uttar Pradesh, India.
  33. Kitwetcharoen H, Phung LT, Klanrit P, Thanonkeo S, Tippayawat P, Yamada M, Thanonkeo P. Kombucha healthy drink—recent advances in production, chemical composition and health benefits.
  34. [Anonymous]. Ayurvedic management of diabetes mellitus type-II: a case study. J Ayurvedic Herb Med. 2020; DOI: 10.31254/jahm.2020.6207.
  35. Carvalho F, Filipe F, Lahlou R, Pires P, Salgado M, Silva LR. Natural functional beverages as an approach to manage diabetes. CPIRN-UDI/IPG—Centro de Potencial e Inovação em Recursos Naturais, Instituto Politécnico da Guarda, Guarda, Portugal; CICS-UBI—Health Sciences Research Center, University of Beira Interior, Covilhã, Portugal; University of Coimbra, Department of Chemical Engineering, Portugal.
  36. Efenberger-Szmechtyk M, Nowak A, Kregiel D. Implementation of chemometrics in quality evaluation of food and beverages. Crit Rev Food Sci Nutr. 2017; DOI: 10.1080/10408398.2016.1276883.
  37. Osuntogun B, Aboaba OO. Microbiological and physico-chemical evaluation of some non-alcoholic beverages. Pak J Nutr. 2004;3(3):188–192.
  38. Aadil RM, Madni GM, Roobab U, Rahman UU, Zeng XA. Quality control in beverage production: an overview. National Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan; School of Food Science and Engineering, South China University of Technology, Guangzhou, China.

Photo
Pooja Mali
Corresponding author

B Pharmacy, SND college of Pharmacy

Photo
Dr. Amol Gayke
Co-author

B Pharmacy, SND college of Pharmacy

Pooja Mali*, Dr. Amol Gayke, Functional Beverage for Pre-Diabetic Patients, Int. J. Sci. R. Tech., 2025, 2 (10), 376-388. https://doi.org/10.5281/zenodo.17442865

More related articles
Formulation and Evalution of Clindamycin Gel...
Deshmukh Ajinkya, Dr. Priti Shinde, ...
Mapping Drug Responses Through Multi-Omics: A New ...
Gargi Bachhav, Samruddhi Avhad, Janhavi Bhalerao, Mukund Pache, A...
Design and Analysis of Adders Using Pass Transisto...
Chaitanya S., Abhishek B. S., Harshavardhan S., Karthik S., Manju...
Repurposing of Fluindione an Anti-Coagulant Drug Against Thymondylate Synthetase...
Sonakshi Lokare, Sakshi Khamkar, Sankalp Karande, Sanika Mithari, Sayali kawade, Namrata koli, Ankit...
Formulation of Fast Dissolving Tablet Using Banana Peel Powder...
Pooja Rathore, Rahul Bisen, Prachi Rahangdale, Pulkit Prajapati, Pradhuuman Patel, Prince Kushwaha, ...
A Review on Role of Colophony in Different Formulation...
Rushikesh Sanap, Sarukh Vikram, Pund Sonali, Bhad Manoj, Araj Ishwar, ...
Related Articles
Dvelopment And Assessment Of A Bcs Class II - SGLT2 (Sodium Glucose Cotransporte...
Dileep J Babu Bikkina, Rajesh Vooturi, Subhash Zade, Narendra Reddy Tharigoppala, Suresh Kumar Joshi...
A Review of Anti-Inflammatory Herbs for Wound Healing: Traditional Knowledge and...
Sakshi Gaikwad, Vikram Sarukh, Gauri Paithankar, Pooja Lasure, Ramdas Darade, ...
Evaluation Of Self Care Practices Among Known Type 2 Diabetic Patients in A Rura...
Dr. Sarmatha V., Satheeshkumar N., Dr. Sangameswaran B., Dr. Kannan S., Palanivel S., Ponnarasan T.,...
Herbal Treatment for Tuberculosis...
Sayyad Kaifali Adam, Tejaswini Gurud, Sarthak Mote , Ajim Shaikh , Sachin Sapkal, Saurabh Walunjkar,...
Formulation and Evalution of Clindamycin Gel...
Deshmukh Ajinkya, Dr. Priti Shinde, ...
More related articles
Formulation and Evalution of Clindamycin Gel...
Deshmukh Ajinkya, Dr. Priti Shinde, ...
Mapping Drug Responses Through Multi-Omics: A New Era of Bioinformatics in Preci...
Gargi Bachhav, Samruddhi Avhad, Janhavi Bhalerao, Mukund Pache, Akshat Bhamare, Sakshi Ahirrao, ...
Design and Analysis of Adders Using Pass Transistor Logic for Multipliers...
Chaitanya S., Abhishek B. S., Harshavardhan S., Karthik S., Manju T. M., ...
Formulation and Evalution of Clindamycin Gel...
Deshmukh Ajinkya, Dr. Priti Shinde, ...
Mapping Drug Responses Through Multi-Omics: A New Era of Bioinformatics in Preci...
Gargi Bachhav, Samruddhi Avhad, Janhavi Bhalerao, Mukund Pache, Akshat Bhamare, Sakshi Ahirrao, ...
Design and Analysis of Adders Using Pass Transistor Logic for Multipliers...
Chaitanya S., Abhishek B. S., Harshavardhan S., Karthik S., Manju T. M., ...